APUS
Apimeds Pharmaceuticals US Inc.

306
Mkt Cap
$26.41M
Volume
512.00
52W High
$4.03
52W Low
$1.37
PE Ratio
-4.83
APUS Fundamentals
Price
$2.08
Prev Close
$2.10
Open
$2.20
50D MA
$2.23
Beta
1.43
Avg. Volume
148,722.53
EPS (Annual)
-$0.1188
P/B
3.21
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Apimeds Pharmaceuticals says I love my Ducks with new ai Futures Lab Program collaboration with the University of Oregons Lundquist College of Business
Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (Apimeds) today announced the expansion of the Apimeds ai Futures Lab program through a new collaboration with the University of Oregons Lundquist...
Business Wire·2mo ago

Latest APUS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.